medmix AG
medmix AG (MEDX.SW) Stock Competitors & Peer Comparison
See (MEDX.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDX.SW | CHF 10.86 | +1.69% | 443.3M | -77.57 | -CHF 0.14 | +4.60% |
| GE.SW | CHF 152.00 | +4.11% | 164.8B | 48.56 | CHF 3.13 | +0.18% |
| SCHP.SW | CHF 305.40 | +0.07% | 31.9B | 33.34 | CHF 9.16 | +1.96% |
| SCHN.SW | CHF 292.50 | +0.00% | 31.4B | 31.86 | CHF 9.18 | +1.96% |
| VACN.SW | CHF 275.50 | +2.04% | 8.3B | 36.98 | CHF 7.45 | +2.27% |
| RAA.SW | CHF 615.00 | +0.00% | 7.7B | 48.08 | CHF 12.79 | +1.99% |
| KGX.SW | CHF 57.36 | N/A | 7.5B | 14.42 | CHF 3.98 | +1.38% |
| GF.SW | CHF 66.05 | +2.09% | 5.4B | 22.31 | CHF 2.96 | +2.04% |
| SUN.SW | CHF 153.80 | +1.59% | 5.2B | 19.27 | CHF 7.98 | +2.76% |
| BUCN.SW | CHF 399.00 | +1.40% | 4.1B | 18.10 | CHF 22.04 | +2.76% |
Stock Comparison
MEDX.SW vs GE.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, GE.SW has a market cap of 164.8B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while GE.SW trades at CHF 152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas GE.SW's P/E ratio is 48.56. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to GE.SW's ROE of +0.21%. Regarding short-term risk, MEDX.SW is less volatile compared to GE.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check GE.SW's competition here
MEDX.SW vs SCHP.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, SCHP.SW has a market cap of 31.9B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while SCHP.SW trades at CHF 305.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas SCHP.SW's P/E ratio is 33.34. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to SCHP.SW's ROE of +0.11%. Regarding short-term risk, MEDX.SW is more volatile compared to SCHP.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check SCHP.SW's competition here
MEDX.SW vs SCHN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, SCHN.SW has a market cap of 31.4B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while SCHN.SW trades at CHF 292.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas SCHN.SW's P/E ratio is 31.86. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to SCHN.SW's ROE of +0.11%. Regarding short-term risk, MEDX.SW is more volatile compared to SCHN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check SCHN.SW's competition here
MEDX.SW vs VACN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, VACN.SW has a market cap of 8.3B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while VACN.SW trades at CHF 275.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas VACN.SW's P/E ratio is 36.98. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to VACN.SW's ROE of +0.30%. Regarding short-term risk, MEDX.SW is less volatile compared to VACN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check VACN.SW's competition here
MEDX.SW vs RAA.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, RAA.SW has a market cap of 7.7B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while RAA.SW trades at CHF 615.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas RAA.SW's P/E ratio is 48.08. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to RAA.SW's ROE of +0.30%. Regarding short-term risk, MEDX.SW is more volatile compared to RAA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check RAA.SW's competition here
MEDX.SW vs KGX.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, KGX.SW has a market cap of 7.5B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while KGX.SW trades at CHF 57.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas KGX.SW's P/E ratio is 14.42. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to KGX.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is more volatile compared to KGX.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check KGX.SW's competition here
MEDX.SW vs GF.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, GF.SW has a market cap of 5.4B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while GF.SW trades at CHF 66.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas GF.SW's P/E ratio is 22.31. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to GF.SW's ROE of +3.63%. Regarding short-term risk, MEDX.SW is less volatile compared to GF.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check GF.SW's competition here
MEDX.SW vs SUN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, SUN.SW has a market cap of 5.2B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while SUN.SW trades at CHF 153.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas SUN.SW's P/E ratio is 19.27. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to SUN.SW's ROE of +0.22%. Regarding short-term risk, MEDX.SW is more volatile compared to SUN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check SUN.SW's competition here
MEDX.SW vs BUCN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, BUCN.SW has a market cap of 4.1B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while BUCN.SW trades at CHF 399.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas BUCN.SW's P/E ratio is 18.10. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to BUCN.SW's ROE of +0.12%. Regarding short-term risk, MEDX.SW is more volatile compared to BUCN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check BUCN.SW's competition here
MEDX.SW vs JUNGH.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, JUNGH.SW has a market cap of 3.5B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while JUNGH.SW trades at CHF 30.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas JUNGH.SW's P/E ratio is 11.61. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to JUNGH.SW's ROE of +0.15%. Regarding short-term risk, MEDX.SW is more volatile compared to JUNGH.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check JUNGH.SW's competition here
MEDX.SW vs KU2.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, KU2.SW has a market cap of 3.3B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while KU2.SW trades at CHF 53.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas KU2.SW's P/E ratio is 36.60. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to KU2.SW's ROE of +0.05%. Regarding short-term risk, Volatility data is not available for a full comparison. MEDX.SW has daily volatility of 2.42 and KU2.SW has daily volatility of N/A.Check KU2.SW's competition here
MEDX.SW vs KARN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, KARN.SW has a market cap of 2.5B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while KARN.SW trades at CHF 330.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas KARN.SW's P/E ratio is 34.43. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to KARN.SW's ROE of +0.31%. Regarding short-term risk, MEDX.SW is more volatile compared to KARN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check KARN.SW's competition here
MEDX.SW vs BCHN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, BCHN.SW has a market cap of 2.4B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while BCHN.SW trades at CHF 724.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas BCHN.SW's P/E ratio is 23.21. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to BCHN.SW's ROE of +0.34%. Regarding short-term risk, MEDX.SW is more volatile compared to BCHN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check BCHN.SW's competition here
MEDX.SW vs WAF.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, WAF.SW has a market cap of 2.2B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while WAF.SW trades at CHF 71.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas WAF.SW's P/E ratio is 6.86. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to WAF.SW's ROE of +0.01%. Regarding short-term risk, MEDX.SW is more volatile compared to WAF.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check WAF.SW's competition here
MEDX.SW vs INRN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, INRN.SW has a market cap of 2B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while INRN.SW trades at CHF 2,365.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas INRN.SW's P/E ratio is 32.85. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to INRN.SW's ROE of +0.14%. Regarding short-term risk, MEDX.SW is more volatile compared to INRN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check INRN.SW's competition here
MEDX.SW vs BLD.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, BLD.SW has a market cap of 1.2B. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while BLD.SW trades at CHF 3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas BLD.SW's P/E ratio is -6.66. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to BLD.SW's ROE of -0.44%. Regarding short-term risk, MEDX.SW is more volatile compared to BLD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check BLD.SW's competition here
MEDX.SW vs OERL.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, OERL.SW has a market cap of 993.7M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while OERL.SW trades at CHF 3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas OERL.SW's P/E ratio is 15.27. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to OERL.SW's ROE of +0.06%. Regarding short-term risk, MEDX.SW is less volatile compared to OERL.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check OERL.SW's competition here
MEDX.SW vs BYS.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, BYS.SW has a market cap of 763.1M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while BYS.SW trades at CHF 369.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas BYS.SW's P/E ratio is -12.83. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to BYS.SW's ROE of -0.10%. Regarding short-term risk, MEDX.SW is less volatile compared to BYS.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check BYS.SW's competition here
MEDX.SW vs KOMN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, KOMN.SW has a market cap of 457.6M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while KOMN.SW trades at CHF 89.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas KOMN.SW's P/E ratio is -49.61. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to KOMN.SW's ROE of -0.01%. Regarding short-term risk, MEDX.SW is less volatile compared to KOMN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check KOMN.SW's competition here
MEDX.SW vs PMN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, PMN.SW has a market cap of 415.5M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while PMN.SW trades at CHF 444.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas PMN.SW's P/E ratio is 12.94. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to PMN.SW's ROE of +0.13%. Regarding short-term risk, MEDX.SW is more volatile compared to PMN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check PMN.SW's competition here
MEDX.SW vs PM.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, PM.SW has a market cap of 402.4M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while PM.SW trades at CHF 419.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas PM.SW's P/E ratio is 10.47. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to PM.SW's ROE of +0.16%. Regarding short-term risk, MEDX.SW is more volatile compared to PM.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check PM.SW's competition here
MEDX.SW vs MTG.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, MTG.SW has a market cap of 369.8M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while MTG.SW trades at CHF 35.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas MTG.SW's P/E ratio is 19.14. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to MTG.SW's ROE of +0.13%. Regarding short-term risk, MEDX.SW is more volatile compared to MTG.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check MTG.SW's competition here
MEDX.SW vs NOEJ.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, NOEJ.SW has a market cap of 367.1M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while NOEJ.SW trades at CHF 73.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas NOEJ.SW's P/E ratio is 43.89. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to NOEJ.SW's ROE of +0.00%. Regarding short-term risk, MEDX.SW is more volatile compared to NOEJ.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check NOEJ.SW's competition here
MEDX.SW vs MIKN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, MIKN.SW has a market cap of 308.3M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while MIKN.SW trades at CHF 18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas MIKN.SW's P/E ratio is 9.69. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to MIKN.SW's ROE of +0.13%. Regarding short-term risk, MEDX.SW is more volatile compared to MIKN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check MIKN.SW's competition here
MEDX.SW vs RIEN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, RIEN.SW has a market cap of 251.8M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while RIEN.SW trades at CHF 55.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas RIEN.SW's P/E ratio is -22.55. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to RIEN.SW's ROE of +0.03%. Regarding short-term risk, MEDX.SW is less volatile compared to RIEN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check RIEN.SW's competition here
MEDX.SW vs STGN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, STGN.SW has a market cap of 177.8M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while STGN.SW trades at CHF 32.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas STGN.SW's P/E ratio is -47.39. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to STGN.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is less volatile compared to STGN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check STGN.SW's competition here
MEDX.SW vs FTON.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, FTON.SW has a market cap of 164.9M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while FTON.SW trades at CHF 11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas FTON.SW's P/E ratio is -3.54. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to FTON.SW's ROE of -0.09%. Regarding short-term risk, MEDX.SW is more volatile compared to FTON.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check FTON.SW's competition here
MEDX.SW vs KLIN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, KLIN.SW has a market cap of 114.9M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while KLIN.SW trades at CHF 13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas KLIN.SW's P/E ratio is 12.26. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to KLIN.SW's ROE of +0.10%. Regarding short-term risk, MEDX.SW is more volatile compared to KLIN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check KLIN.SW's competition here
MEDX.SW vs TOHN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, TOHN.SW has a market cap of 101M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while TOHN.SW trades at CHF 5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas TOHN.SW's P/E ratio is 8.53. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to TOHN.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is less volatile compared to TOHN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check TOHN.SW's competition here
MEDX.SW vs STRN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, STRN.SW has a market cap of 23.9M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while STRN.SW trades at CHF 21.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas STRN.SW's P/E ratio is -33.23. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to STRN.SW's ROE of +0.04%. Regarding short-term risk, MEDX.SW is less volatile compared to STRN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check STRN.SW's competition here
MEDX.SW vs PEDU.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, PEDU.SW has a market cap of 6.7M. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while PEDU.SW trades at CHF 56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas PEDU.SW's P/E ratio is -3.89. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to PEDU.SW's ROE of -0.01%. Regarding short-term risk, MEDX.SW is more volatile compared to PEDU.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MEDX.SW.Check PEDU.SW's competition here
MEDX.SW vs BOBNN.SW Comparison August 2025
MEDX.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDX.SW stands at 443.3M. In comparison, BOBNN.SW has a market cap of 0. Regarding current trading prices, MEDX.SW is priced at CHF 10.86, while BOBNN.SW trades at CHF 57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDX.SW currently has a P/E ratio of -77.57, whereas BOBNN.SW's P/E ratio is N/A. In terms of profitability, MEDX.SW's ROE is -0.02%, compared to BOBNN.SW's ROE of +0.17%. Regarding short-term risk, MEDX.SW is less volatile compared to BOBNN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MEDX.SW.Check BOBNN.SW's competition here